Biomedical applications of glycosylphosphatidylinositol-anchored proteins

J Lipid Res. 2016 Oct;57(10):1778-1788. doi: 10.1194/jlr.R070201. Epub 2016 Aug 19.

Abstract

Glycosylphosphatidylinositol (GPI)-anchored proteins (GPI-APs) use a unique posttranslational modification to link proteins to lipid bilayer membranes. The anchoring structure consists of both a lipid and carbohydrate portion and is highly conserved in eukaryotic organisms regarding its basic characteristics, yet highly variable in its molecular details. The strong membrane targeting property has made the anchors an interesting tool for biotechnological modification of lipid membrane-covered entities from cells through extracellular vesicles to enveloped virus particles. In this review, we will take a closer look at the mechanisms and fields of application for GPI-APs in lipid bilayer membrane engineering and discuss their advantages and disadvantages for biomedicine.

Keywords: cancer; gene therapy; human immunodeficiency virus; immunology; lipid rafts; membranes; molecular painting; tumor therapy; viral envelope.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Eukaryotic Cells
  • GPI-Linked Proteins / chemistry*
  • GPI-Linked Proteins / metabolism
  • Humans
  • Lipid Bilayers / chemistry*
  • Lipid Bilayers / metabolism
  • Oligosaccharides / chemistry*
  • Protein Processing, Post-Translational*
  • Virion / chemistry*
  • Virion / metabolism

Substances

  • (6-O-aminoethylphosphonato-mannopyranosyl)-(1-2)-mannopyranosyl-(1-6)-mannopyranosyl-(1-4)-(2-amino-2-deoxyglucopyranosyl)-(1-6)-1-O-(1,2-di-O-octadecanoyl-sn-glyceryl-phosphonato)-myo-inositol
  • GPI-Linked Proteins
  • Lipid Bilayers
  • Oligosaccharides